Open AccessS120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON‐OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
Author(s) -
Inusa B,
Hamdy M,
ElBeshlawy A,
Ebeid F,
Kwiatkowski J,
Kanter J,
Williams S,
Lee D,
Temin N,
Fradette C,
Tricta F,
Elalfy M
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000821448.70992.5a
Subject(s) - deferiprone , medicine , deferoxamine , clinical endpoint , population , anemia , deferasirox , sickle cell anemia , thalassemia , adverse effect , randomized controlled trial , subgroup analysis , pediatrics , clinical trial , disease , meta analysis , environmental health